selenium has been researched along with sorafenib in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Chen, T; Huang, X; Li, C; Lin, W; Lin, X; Yang, F; Zheng, L | 1 |
Abdel-Hamed, AR; Abo-Elmatty, DM; Abulsoud, AI; Al-Noshokaty, TM; Mesbah, NM | 1 |
Fan, SY; He, LJ; Jia, YL; Li, S; Nan, X; Pei, XT; Wang, DX; Wang, HY; Wang, XK; Xi, JF; Xu, YC; Yue, W; Zeng, Q; Zhang, B; Zhang, M; Zhang, MM; Zhong, W; Zhou, JN; Zhou, XB | 1 |
Goltyaev, MV; Gudkov, SV; Simakin, AV; Turovsky, EA; Varlamova, EG | 1 |
Gudkov, SV; Khabatova, VV; Turovsky, EA; Varlamova, EG | 1 |
5 other study(ies) available for selenium and sorafenib
Article | Year |
---|---|
Thermosensitive hydrogels for sustained-release of sorafenib and selenium nanoparticles for localized synergistic chemoradiotherapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoradiotherapy; Delayed-Action Preparations; Female; Humans; Hydrogels; Liver Neoplasms; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Nanoparticles; Selenium; Sorafenib | 2019 |
Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis.
Topics: Animals; Antineoplastic Agents; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Glypicans; Liver Neoplasms; Mammals; Nanoparticles; NF-kappa B; Proto-Oncogene Proteins c-akt; Rats; RNA, Long Noncoding; Selenium; Sorafenib; Thioacetamide; TOR Serine-Threonine Kinases | 2022 |
A Functional Screening Identifies a New Organic Selenium Compound Targeting Cancer Stem Cells: Role of c-Myc Transcription Activity Inhibition in Liver Cancer.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Early Detection of Cancer; Liver Neoplasms; Mice; Molecular Docking Simulation; Neoplastic Stem Cells; Selenium; Selenium Compounds; Sorafenib | 2022 |
Comparative Analysis of the Cytotoxic Effect of a Complex of Selenium Nanoparticles Doped with Sorafenib, "Naked" Selenium Nanoparticles, and Sorafenib on Human Hepatocyte Carcinoma HepG2 Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Nanoparticles; Selenium; Sorafenib | 2022 |
Ca
Topics: Antineoplastic Agents; Apoptosis; Astrocytes; Cell Line, Tumor; Glioblastoma; Humans; Niacinamide; Phenylurea Compounds; Selenium; Sorafenib | 2023 |